Prescription Drug Marketing Act of 1986
Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to ban the reimportation of drugs produced in the United States, to place retrictions on drug samples,… Show full official titleShow less
Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to ban the reimportation of drugs produced in the United States, to place retrictions on drug samples, to ban certain resales of drugs purchased by hospitals and other health care facilities, and for other purposes.
More subjectsShow fewer subjects
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Ordered to be Reported (Amended).
Prescription Drug Marketing Act of 1986 - Amends the Federal Food, Drug, and Cosmetic Act to permit only the U.S. manufacturer of a drug to reimport such drug into the United States.
Prohibits the sale of prescription drug samples. Permits the distribution of samples only to practitioners licensed to prescribe such drugs. Requires such practitioners to return a receipt for such drug samples to the manufacturers to be kept and made available to Federal and State officials.
Requires drug wholesalers to provide drug purchasers with a statement identifying the manufacturer and each sale of the drug. Directs the Secretary of Health and Human Services to issue licensing standards for drug wholesalers.
Cite this page
U.S. Congress. (2026). H.R. 4820: Prescription Drug Marketing Act of 1986. 99th Congress. Open America. https://openamerica.io/bill/99-HR-4820/
"H.R. 4820: Prescription Drug Marketing Act of 1986." 99th Congress, 2026, Open America, https://openamerica.io/bill/99-HR-4820/.
H.R. 4820, 99th Cong. (2026), https://openamerica.io/bill/99-HR-4820/.
[H.R. 4820: Prescription Drug Marketing Act of 1986](https://openamerica.io/bill/99-HR-4820/)